Methyl hydrazinecarbimidothioate hydroiodide
CAS: 35600-34-1
Ref. 3D-FM133227
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 25g | A consultar |
Informação sobre produto
- Hydrazinecarboximidothioic acid methyl ester hydroiodide
- Carbamohydrazonothioic Acid, Methyl Ester
Methyl hydrazinecarbimidothioate hydroiodide (MHCDI) is an anti-cancer drug that belongs to the group of alkylating agents. It is a prodrug that must be activated by intramolecular hydrogen chloride to form methyl hydrazine, which reacts with the DNA nucleotide bases. MHCDI is used in clinical studies for the treatment of pancreatic cancer, colorectal cancer, and other cancers. MHCDI is administered intravenously, orally, or intraperitoneally. MHCDI binds to nitrogen atoms in the vasoactive intestinal peptide and reacts with hydrochloric acid to form a pyrazole ring. The reaction products are then excreted from the body.
Propriedades químicas
Consulta técnica sobre: 3D-FM133227 Methyl hydrazinecarbimidothioate hydroiodide
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
